Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3088% below fair value
$2.07−0.18 (-8.00%)
Close on Nov 19, 2026Market cap $305.92MP/E –Yield –
Tilray Brands free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Tilray Brands's free cash flow for the twelve months ending May 31, 2025 was -$127.52M. For fiscal 2025 it was -$127.52M. The highest annual figure on record is -$3.81M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 31, 2025 | -$127.52M | – |
| FY2024 | May 31, 2024 | -$60.15M | – |
| FY2023 | May 31, 2023 | -$12.89M | – |
| FY2022 | May 31, 2022 | -$211.33M | – |
| FY2019 | Dec 31, 2019 | -$331.81M | – |
| FY2018 | Dec 31, 2018 | -$96.45M | – |
| FY2017 | Dec 31, 2017 | -$16.91M | – |
| FY2016 | Dec 31, 2016 | -$3.81M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$19.14M | -191.1% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$20.18M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$46.16M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$42.04M | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $21.00M | -32.7% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$24.89M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$36.27M | -247.0% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$19.99M | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $31.19M | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$19.49M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $24.67M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$49.27M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$26.12M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$51.00M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$24.66M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$109.54M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$114.13M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$81.19M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$102.63M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$33.86M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$31.93M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$33.37M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$16.56M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$14.58M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -$6.72M | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -$6.55M | – |
See a number that looks wrong?